The company has already demonstrated the value of its technology in two approved products, namely Yorvipath (palopegteriparatide), a modified version of parathyroid hormone (PTH), which is for the treatment of hypoparathyroidism in adults, and Skytrofa (lonapegsomatropin), a long-acting growth hormone for children with growth hormone deficiency
Flexible Dosing Formats: Available in 5mg/5mg or 10mg/10mg configurations
[PubMed: 25631887] For many workflows, labs keep a master vial protected from routine handling, and prepare smaller working aliquots to reduce exposure
NAD+ infusions help replenish these levels, supporting brain health, metabolism, immune function, and cellular repair
Monitoring Metabolic Health and Long-Term Tolerability Long-term weight loss requires ongoing attention to metabolic health, even once patients appear stable on their medication